We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Vitalea Science Completes Dermal Distribution Microdose Study

News   Jun 11, 2007

 
Vitalea Science Completes Dermal Distribution Microdose Study
 
 
 

RELATED ARTICLES

More Effective Drug Combination Regimens to Treat TB Faster

News

UCLA researchers have identified a way to significantly reduce the duration of tuberculosis treatment using an approach called "artificial intelligence-parabolic response surface."

READ MORE

Statins’ Potential to Treat MS Unrelated to Lowering Cholesterol

News

The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS) - for reasons that might be unrelated to the drug’s intended cholesterol lowering affects, a UCL study has found.

READ MORE

Designing “Smart” Drugs to Prevent Malaria Treatment Resistance

News

Researchers at the Crick and Imperial College London have generated malaria parasites resistant to a promising new class of candidate antimalarial drugs. By analyzing the structural changes behind the resistance, they identified novel compounds that were immune to this mechanism of resistance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE